INTRODUCTION
============

The fact that the ozone is a potent oxidant accounts for its high reactivity. This gas dissolves in the plasma, extracellular fluids, the thin layer of water which covers the skin and in regions coated by mucosa, triggering reactions with a number of molecules present in biological fluids, such as antioxidants, proteins, carbohydrates, and, mainly, with polyunsaturated fatty acids. By these reactions, reactive oxygen species (ROS) and lipid oxidation products (LOPs) are generated, both responsible for successive and multiple biochemical reactions that occur in different body cells (5).

The ozone in its gaseous or aqueous phases is effective against the majority of microorganisms tested by numerous research groups (2, 4, 5, 6, 26). Low concentrations and short-term contact are enough to inactivate bacteria, mold yeast, protozoa algae and fungi (10, 11, 12, 20). The mechanism of antimicrobial action occurs due to the membrane lysis of the agents, after the oxidation process (14). It is believed that the primary attack is against the cellular wall of the microorganism and, following, on penetrating the interior of cell, the ozone promotes oxidation of amino and nucleic acids. The cellular lysis depends on the extension of such reactions (25).

The ozonized olive oil has been currently used for topic treatments of wounds, anaerobic and herpes infections, ulcers and trophic burns, cellulite, abcesses, anal fissures, decubitus ulcers, fistules, furunculosis, gingivitis, vulvovaginitis, fungical illnesses (5, 23, 24) and epidermal infections (3). The antimicrobial activity of the ozonized sunflower oil has brought valuable contribution against bacteria, viruses and fungi (15, 16, 17, 21).

*Microsporum canis* is an important agent of dermatophitosis in human and animal (7, 22). This worldly distributed *canis* variety is the most common zoophilia species in human infections. The lesions caused by this dermatophite are usually located on the skin and pelage and commonly cause *tinea capitis* and *tinea corporis* in children and adults who had contact with dogs or cats (mainly reservoirs), or infected children (13). In animals, while the dogs develop tegumentary lesions, the cats, otherwise, remains asymptomatic or shows tiny lesions; such peculiarity makes the cats a serious threat to the control of the microsporum dermatophitosis (7).

The aim of the present study was to assess the efficacy of the ozonized oil against *Microsporum canis* in rabbits*.*

MATERIALS AND METHODS
=====================

Eighteen male New Zealand white rabbits, weighing between 2 and 3.2 kg were used in this study. The animals were kept in the biotery of UTECE (Unity of Surgical Technique and Experimental Surgery of Irmandade da Santa Casa de Misericórdia de São Paulo), confined in individual cages under controlled temperature (15 to 20° C), humidity of 55 ± 10%, and maintained under uniform circadian rhythm with lighting schedule of 12 hours (dark) and 12 hours (light). Food and water were offered *ad libitum*.

After one week of adaptation, the animals were inoculated
---------------------------------------------------------

The Research Project has been approved by the Ethics in Animal Experimentation Committee of the Faculty of Medical Sciences of Santa Casa de São Paulo, under protocol number 159, according to the "Guide for the Care and Use of Laboratory Animals" and "Ethical Principles in Animal Experimentation of the Brazilian College of Animal Experiments".

Preparation of the inoculation broth
------------------------------------

For the culture broth, a sample of human scalp contaminated with a strain of *Microsporum canis* was collected (patient MMC -- sample collected on 28/07/2008 in the Dermatology Service of Santa Casa de Misericórdia de São Paulo). That strain was cultivated in Sabouraud Agar and kept at room temperature until the growth of the fungus, in the Laboratory of Microbiology of Faculty of Medical Sciences of Santa Casa de São Paulo. The broth was prepared using 10ml of TSB (Tryptic Soy Broth) and inoculation of *Microsporum canis* at 10^9^ UFC/ml concentration.

Inoculation
-----------

The animals were tranquilized with an intramuscular injection of 2 to 2.5ml of acepromazine 0.2%, 15 to 20 minutes prior to the procedure. Following, depilation in the four dorsal regions of the animals were performed: right dorso-lateral cranial and right caudal, and left dorso-lateral cranial and left caudal. An appropriate shearing machine and a number 40 blade (surgical) were used in order to obtain depilated places of around 36 square centimeters ([Figure 1](#fig1){ref-type="fig"}).

In the center of each square, a circumference of 2cm diameter was delimited with permanent ink ([Figure 2](#fig2){ref-type="fig"}), followed by superficial scarification of the circumferences of the right dorso-lateral cranial, left dorso-lateral cranial, and left dorso-lateral caudal regions using a no. 22 scalpel blade. Subsequently, the three scarified regions underwent inoculation by a sterile swab embedded in *Microsporum canis* broth.

After the inoculations, the places were maintained uncovered and the animals were kept free in their cages. The right dorso-lateral caudal region did not undergo scarification or inoculation. It was only demarcated the place where the ozonized oil would be applied.

![Preparation of the rabbit, with depilation of a 36cm^2^ area in the right dorsolateral cranial region for subsequent inoculation using *M. canis*, and the right caudal region which was not scarified or inoculated.](bjm-42-274-g001){#fig1}

![Left dorsolateral cranial and caudal regions of the rabbit, marked out centrally with a 2cm circumference for subsequent scarification and inoculation using *M. canis*.](bjm-42-274-g002){#fig2}

Mycological examination
-----------------------

The mycological examination was performed at days 0 (prior to inoculation) and 7, 14, 21 and 28 post-inoculation. The samples were collected from the regions through friction with a sterile swab, humidified with sterile saline solution. The material collected was kept in Stuart's medium until the cultivation of the material in Sabouraud agar. The plates were maintained at room temperature and analyzed, searching for growth of *Microsporum canis.* All plates were read at day 15 of cultivation.

Treatment of the lesions
------------------------

The initial lesions, suggestive of dermatophitosis by *Microsporum canis,* were detected around days 5 to 7 post-inoculation and were confirmed through culture of the suspect material. The treatment of the lesions began at day 7 post-inoculation and the regions were standardized and identified for treatment as follows:-right dorso-lateral cranial region -- treated once a day with 0.12g of terbinaphine 1% cream, for 28 days -- denominated TM region (terbinaphine and *Microsporum canis*);-Right dorso-lateral caudal region -- treated once a day with 0.12g of ozonized oil, for 28 days - denominated O region (ozonized oil);-left dorso-lateral cranial region -- treated once a day with 0.12g of ozonized oil, for 28 days -- denominated OM region (ozonized oil and *Microsporum canis*);-left dorso-lateral caudal region -- no treatment received and region monitored for 28 days -- denominated M region (*Microsporum canis*).

Precision scales were used daily (Denver Instrument Company AA-200) to weigh the medication.

Ozonized oil
------------

The ozonized oil Bioperoxoil®, originally from Barcelona, Spain, was used for the treatment of regions O and OM.

Statistical methodology
-----------------------

To assess the qualitative variables, the oucomes were presented through absolute and relative frequencies. These analyses were performed using the McNemar Test. It was established the significance level of 5%.

Resume measurements were calculated for the quantitative variables. The comparison between the quantitative variables was performed using the Paired t Test. The significance level was established at 5%.

RESULTS
=======

Twenty-eight days after the onset of the treatment, the actions of the terbinaphine 1% cream and the ozonized oil were equivalent ([Table 1](#tbl1){ref-type="table"}).

The individual evolution of each treatment is shown in [Tables 2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}. The regions treated with the ozonized oil (OM) and the non-treated areas are shown in [Table 4](#tbl4){ref-type="table"}, whereas the regions treated (TM) and non-treated with terbinaphine 1% cream are in [Table 5](#tbl5){ref-type="table"}.

It is noteworthy that the statistical analysis of [Tables 4](#tbl4){ref-type="table"} and [5](#tbl5){ref-type="table"} was not possible, since all M regions were contaminated at the end of the study.

As regards the clinical evaluation of the regions, [Figures 3A, B and C](#fig3){ref-type="fig"}, representing regions TM, OM and M, respectively, show lesions formed at week 1 post-inoculation with *Microsporum canis.* [Figure 4](#fig4){ref-type="fig"} shows the evolution of lesion ([Figure 3A](#fig3){ref-type="fig"}) treated with terbinaphine 1% cream for 21 days. [Figure 5](#fig5){ref-type="fig"} refers to the treatment of lesion of figure 3B with ozonized oil for 21 days. Finally, [Figure 6](#fig6){ref-type="fig"} shows the initial lesion ([Figure 3C](#fig3){ref-type="fig"}) without any treatment, after 21 days.

###### 

Comparison between treatments with ozonized oil and terbinaphine 1% cream at the end of treatment.

  **OM~end~**         **TM~end~**   **Total**           
  ------------------- ------------- ----------- ------- ----
  Non- contaminated   n             4           3       7
  \%                  57.1          42.9        100.0   
  Contaminated        n             8           3       11
  \%                  72.7          27.3        100.0   
  Total               n             12          6       18
  \%                  66.7          33.3        100.0   

p=0.227
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###### 

Comparison between treatment with terbinaphine 1% at the initial moment (7 days of inoculation) and at the end of treatment.

  **TM~initial~**     **TM~end~**   **Total**           
  ------------------- ------------- ----------- ------- ----
  Non- contaminated   n             2           2       4
  \%                  50.0          50.9        100.0   
  Contaminated        n             10          4       14
  \%                  71.4          28.6        100.0   
  Total               n             12          6       18
  \%                  66.7          33.3        100.0   

p=0.039
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###### 

Comparison between treatment with ozonized oil at the initial moment (7 days of inoculation) and at the end of treatment.

  **OM~initial~**     **OM~end~**   **Total**           
  ------------------- ------------- ----------- ------- ----
  Non- contaminated   n             3           0       3
  \%                  100.0         0.0         100.0   
  Contaminated        n             4           11      15
  \%                  26.7          73.3        100.0   
  Total               n             7           11      18
  \%                  38.9          61.1        100.0   

p= 0.125 

OM

initial

-- ozonized oil and

Microsporum canis

at the inicial moment;

OM

end

-- ozonized oil and

Microsporum canis

at the end of treatment (28 dias).

###### 

Comparison between areas treated with ozonized oil (OM) and non-treated areas at the final moment.

  **OM~end~**         **OM~end~**   **Total**   
  ------------------- ------------- ----------- ----
  Non- contaminated   n             7           7
  \%                  100.0         100.0       
  Contaminated        n             11          11
  \%                  100.0         100.0       
  Total               n             18          18
  \%                  100.0         100.0       

p= 0.125
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###### 

Final comparison between areas treated with terbinaphine 1% cream (TM) and non-treated areas (M).

  **TM~end~**         **M~end~**   **Total**   
  ------------------- ------------ ----------- ----
  Non- contaminated   n            12          12
  \%                  100.0        100.0       
  Contaminated        n            6           6
  \%                  100.0        100.0       
  Total               n            18          18
  \%                  100.0        100.0       

p= 0.125
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![A. TM region seven days post-inoculation using *M. canis*, revealing marked erythematous area and slight desquamation of the lesion, B. OM region seven days post-inoculation using *M. canis*, revealing marked erythema, C. M region seven days post-inoculation showing marked erythema and slight desquamation of the lesion.](bjm-42-274-g003){#fig3}

![TM region 21 days after treatment with terbinafine cream, evidencing local hair regrowth and absence of erythema or desquamation.](bjm-42-274-g004){#fig4}

![OM region 21 days after treatment with ozonized oil showing hair regrowth, absence of erythema or desquamation, and slight yellowish coloration due to accumulation of oil following a series of daily applications of the product.](bjm-42-274-g005){#fig5}

![M region after 21 days without treatment evidencing marked erythema, absence of hair regrowth and formation of crust over lesion.](bjm-42-274-g006){#fig6}

DISCUSSION
==========

The statistical evaluation of data shows that the action of the ozonized oil and terbinaphine cream was similar ([Table 1](#tbl1){ref-type="table"}). However, the individual evolution of each treatment was different ([Tables 2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}), evidencing that the terbinaphine cream was more efficient in the fungus elimination, and also that there were signs of the action of the ozonized oil against *Microsporum canis.*

The comparisons among the treated regions, both with ozonized oil and terbinaphine cream, and the non-treated regions ([Tables 4](#tbl4){ref-type="table"} and [5](#tbl5){ref-type="table"}) show that the treatment with either therapy brought positive results, since the non-treated regions were all infected by the fungus in the final evaluation at day 28.

There was clinical evidence of improvement of the lesions treated with either products ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). The daily observation revealed a fast improvement of the lesion with the use of terbinaphine cream ([Figure 4](#fig4){ref-type="fig"}). Although the areas treated with ozonized oil also showed improvement ([Figure 5](#fig5){ref-type="fig"}), it was a slower process if compared with the treatment with terbinaphine. The latter showed clear reduction in erythema, gradual repilation of the affected places and a reduction in the scaly and encrusted areas. In the non-treated areas, hyperemic portions lasted longer and there were more intense encrusted and scaly areas.

The imbalance between the scarcity of articles related to the use of ozonized oil in the treatment of fungical illnesses and the more abundant studies on its germicide activitiy over bacteria (1, 8, 21) draws attention and causes surprise, since there is a large number of concordant studies in the literature regarding the ozone as a fungical product (15, 16). The mechanism of action seems to be related to the diffusion of the ozone through the fungical wall and into the interior of the cytoplasm breaking, this way, the vital cellular function. The cellular wall seems to be a possible site of oxidative inactivation of the ozone (23).

Some works found good outcomes from ozonized oil over certain fungi. One study, comprising 257 patients with foot lesions characteristic of epidermophitosis, consisted of a treatment with twice-daily topic application of the oil onto the affected areas. This treatment accomplished a rate of 88.3% of clinical cure in 227 patients, the highest cure rate for scaly epidermophitosis (17). The efficacy of the ozonized sunflower oil was also evaluated in 200 patients for the treatment of *tinea pedis*, in comparison with the use of ketoconazole 2%. Total clinical and mycological cure was accomplished in 75% and 81% of cases treated with Oleozon® and ketoconazole, respectively, with no significant differences between the two groups. The authors of that study regard the ozonized oil as an effective and low-cost antimycotic drug (18).

Two case reports show the efficacy of ozonized oil against onicomicosys in human patients infected by *Trichophyton beigelli* and *T. rubrum*, respectively. The product was applied twice a day and, subsequently, the affected area covered with PVC. The clinical and mycological cure occurred in 90 days (9).

In the current experiment, particular attention was paid to the growth or non-growth of *Microsporum canis* in the mycological studies. There was no intention to clarify whether the ozonized oil has a fungistatic effect; nevertheless, if it does, this data may account for the fact that the clinical improvement of lesions with the oil was slower in comparison with the use of terbinaphine, a well-proven fungicide product (19).

In conclusion, according to the present study, there is statistical indication that the ozonized oil acts against *Microsporum canis* and there is clinical evidence of its action over this dermatophyte.
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